Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994-2006

Contraception

Volumn 83, Issue 6, 2011, Pages 549-555

  Polis, Chelsea B ^a   Gray, Ronald H ^a   Lutalo, Tom ^b   Nalugoda, Fred ^b   Kagaayi, Joseph ^b   Kigozi, Godfrey ^b   Kiwanuka, Noah ^c   Serwadda, David ^c   Wawer, Maria J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

HIV; Hormonal contraception; Implants; Injectable contraception; Oral contraceptive pills; Uganda

Indexed keywords

CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; BREAST FEEDING; CONDOM; CONTRACEPTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FAMILY PLANNING; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MARRIAGE; OPPORTUNISTIC INFECTION; PARITY; PREGNANCY; RURAL POPULATION; SOCIAL STATUS; TREND STUDY; UGANDA;

ADOLESCENT; ADULT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV INFECTIONS; HUMANS; RURAL POPULATION; UGANDA; YOUNG ADULT;

EID: 79955932522     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.10.002     Document Type: Article

References (24)

1. Conde-Agudelo A, Belizan JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ 2000;321:1255-9.
2. DaVanzo J, Razzaque A, Rahman M, et al. The effects of birth spacing on infant and child mortality, pregnancy outcomes, and maternal mortality in Matlab Bangladesh. Santa Monica, California: RAND Corporations Publications Department. Working Paper 2004:198.
3. USAID, UNAIDS, WHO, et al. Coverage of selected services for HIV/ AIDS prevention, care and support in low and middle income countries in 2003. Washington, DC: Policy Project; 2004.
4. Palmer S, Boltz V, Martinson N, et al. Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A 2006;103:7094-9.
5. Arrive E, Newell ML, Ekouevi DK, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 2007;36:1009-21. (Pubitemid 350018545)
6. Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med 2007;356:135-47. (Pubitemid 46089674)
7. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007;197:144-8.
8. Polis CB, Wawer MJ, Kiwanuka N, et al. Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda. AIDS 2010;24:1937-44.
9. Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009;23:S55-67.
10. Massad LS, Evans CT, Wilson TE, et al. Contraceptive use among US women with HIV. J Womens Health 2007;16:657-66.
11. Clark RA, Theall KP. Trends and correlates of hormonal contraception use among HIV-infected women. JAIDS 2004;36:986-8. (Pubitemid 38944095)
12. Galavotti C, Cabral R, Garguillo P, Green B, Gielen A, Fogarty L. Predicting contraceptive use among women at risk for or infected with HIV (abstract no Th.D.240). Atlanta (Ga): International Conference on AIDS; 1996.
13. Desgrees-Du-Lou A, Msellati P, Viho I, et al. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. Int J STD AIDS 2002;13:462-8.
14. Balkus J, Bosire R, John-Stewart G, et al. High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya. Sex Transm Dis 2007;34:25-9.
15. Stephenson R, Koenig MA, Ahmed S. Domestic violence and contraceptive adoption in Uttar Pradesh, India. Stud Fam Plann 2006;37: 75-86.
16. Fanslow J, Whitehead A, Silva M, et al. Contraceptiveuse andassociations with intimate partner violence among a population-based sample of New Zealand women. Aust N Z J Obstet Gynaecol 2008;48:83-9. (Pubitemid 351246273)
17. McCarraher DR, Martin SL, Bailey PE. The influence of method-related partner violence on covert pill use and pill discontinuation among women living in La Paz, El Alto and Santa Cruz, Bolivia. J Biosoc Sci 2006;38:169-86. (Pubitemid 44367108)
18. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998;12:1211-25. (Pubitemid 28302424)
19. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353:525-35. (Pubitemid 29078422)
20. Kagaayi J, Gray RH, Brahmbhatt H, et al. Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda. PLoS One 2008;e3877:3.
21. Uganda Bureau of Statistics (UBOS), Macro International. Uganda Demographic and Health Survey 2006. Calverton (Md): UBOS and Macro International, Inc; 2007.
22. Lutalo T, Kiddugavu M, Wawer MJ, et al. Trends and determinants of contraceptive use in Rakai District, Uganda, 1995-98. Stud Fam Plann 2000;31:217-27.
23. Kiddugavu M, Makumbi F, Wawer MJ, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003;17:233-40. (Pubitemid 36183050)
24. World Health Organization. Strategic approaches to the prevention of HIV infection in infants: Report of a WHO meeting, Morges, Switzerland. Geneva, Switzerland: WHO; 2003.